5027-30-5 Usage
Uses
Used in Pharmaceutical Applications:
Phloracetophenone 4'-O-glucoside is used as a pharmaceutical agent for its potential antioxidant and anti-inflammatory properties. It can be utilized in the development of treatments for various diseases and conditions that benefit from these properties.
Used in Food Industry:
Phloracetophenone 4'-O-glucoside is used as a natural preservative and flavoring agent in food products. Its potential as a preservative can help extend the shelf life of food items, while its flavoring properties can enhance the taste and aroma of various dishes.
Used in Agriculture:
Phloracetophenone 4'-O-glucoside is used in agriculture as a natural pesticide or growth promoter. Its potential pharmacological properties may provide benefits in protecting crops from pests or promoting plant growth, contributing to sustainable agricultural practices.
Overall, Phloracetophenone 4'-O-glucoside shows promise as a versatile compound with various potential applications in the fields of medicine, food, and agriculture.
Check Digit Verification of cas no
The CAS Registry Mumber 5027-30-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,2 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5027-30:
(6*5)+(5*0)+(4*2)+(3*7)+(2*3)+(1*0)=65
65 % 10 = 5
So 5027-30-5 is a valid CAS Registry Number.
5027-30-5Relevant academic research and scientific papers
Exploring the aglycon promiscuity of a new glycosyltransferase from Pueraria lobata
Sun, Lili,Chen, Dawei,Chen, Ridao,Xie, Kebo,Liu, Jimei,Yang, Lin,Dai, Jungui
supporting information, p. 1518 - 1521 (2016/03/12)
Enzymatic glycosylation catalyzed by glycosyltransferases has great potential for creating bioactive glycosylated small-molecule compounds. Here, we highlight the aglycon promiscuity of a new glycosyltransferase (PlGT7) from Pueraria lobata. PlGT7 exhibited the capability to glycosylate 26 structurally diverse drug-like scaffolds and simple phenolics with UDP-glucose to form O-, S-, and N-glycosides. The reversibility of PlGT7 coupled with its substrate flexibility was also exploited to generate bioactive glucosides with simple sugar donor. These studies indicate the significant potential of an enzymatic approach to the glycosylation of bioactive natural and unnatural products in drug discovery.
